|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study显示文摘Improved surgical techniques and greater efficacy of new anti-rejection drugs have significantly improved the survival of patients undergoing orthotopic liver transplantation(OLT). This has led to an increased incidence of metabolic disorders as well as cardiovascular and cerebrovascular diseases as causes of morbidity and mortality in OLT patients. In the last decade, several studies have examined which predisposing factors lead to increased cardiovascular risk(i.e., age, ethnicity, diabetes, NASH, atrial fibrillation, and some echocardiographic parameters) as well as which factors after OLT(i.e., weight gain, metabolic syndrome, immunosuppressive therapy, and renal failure) are linked to increased cardiovascular mortality. However, currently, there are no available data that evaluate the development of atherosclerotic damage after OLT. The awareness of high cardiovascular risk after OLT has not only lead to the definition of new but generally not accepted screening of high risk patients before transplantation, but also to the need for careful patient follow up and treatment to control metabolic and cardiovascular pathologies after transplant. Prospective studies are needed to better define the predisposing factors for recurrence and de novo occurrence of metabolic alterations responsible for cardiovascular damage after OLT. Moreover, such studies will help to identify the timing of disease progression and damage,which in turn may help to prevent morbidity and mortality for cardiovascular diseases. Our preliminary results show early occurrence of atherosclerotic damage, which is already present a few weeks following OLT, suggesting that specific, patient-tailored therapies should be started immediately post OLT. | Giuseppina Pisano Anna L Fracanzani Lucio Caccamo Maria F Donato Silvia Fargion | 2016 | World Journal of Gastroenterology2016，22，40： | 4 |
| 2 | Rosiglitazone, a ligand of the peroxisome proliferator-activated receptorgamma, reduces acute pancreatitis induced by cerulein 显示文摘 | Cuzzocrea S Pisano B Dugo L | 2004 | Intensive Care Med2004，30，5： | 1 |
| 3 | Late occlusion of aortofemoral bypass graft:surgical treatment显示文摘 | Pedrini L Pisano E Donato DPM | 1994 | Cardiovasc Surg1994，2，： | 1 |
| 4 | Rosiglitazone and 15 deoxy-Delta12, 14-prostaglandin J2, ligands of the peroxisome proliferator activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut显示文摘 | Cuzzocrea S Pisano B Dugo L | 2003 | Br J Pharmacol2003，140，2： | 1 |
| 5 | Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2,ligands of the peroxisome proliferator-activated receptor-γ(PPAR-γ),reduce ischaemia/reperfusion injury of the gut显示文摘 | Cuzzocrea S Pisano B Dugo L | 2003 | Bri J Pharmacol2003，140，： | 1 |
| 6 | Rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2,ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma),reduce ischaemia/reperfusion injury of the gut显示文摘 | Cuzzocrea S Pisano B Dugo L | 2003 | Br J Pharmacol2003，140，： | 1 |
| 7 | Rosiglitazone,a ligand of the peroxisome proliferator-activated receptorgamma,reduces the development of nonseptic shock induced by zymosan in mice显示文摘 | Cuzzocrea S Pisano B Dugo L | 2004 | Crit Care Med2004，32，： | 1 |
| 8 | Modeling and optimal design of piezoelectric cantilever microactuators 显示文摘 | PISANO A P | 1997 | Journal of Microelectromechanical Systems1997，6，3： | 1 |
| 9 | Liquid-vapor phase transition and bubble formation in micro structures 显示文摘 | Lin L W Udell K Pisano A | 1994 | Thermal Sci- ence and Engineering1994，2，1： | 1 |
| 10 | Assessment of fluid-responsiveness parameters for off-primp coronary artery bypass surgery: a comparison among LiDCO, transesophageal echocardiography, and pulmonary artery catheter显示文摘 | Belloni L Pisano A Natale A | 2008 | J Cardiothorac Vasc Anesth2008，22，： | 1 |
| 11 | Novel folate binding protein - 1 interactions in embryonic orofacial tissue 显示文摘 | Pisano MM Bhattacherjee V Wong L | 2010 | Life Sci2010，86，78： | 1 |
| 12 | Rosiglitazone, a ligand of the peroxisome proliferator - activated receptor - gamma, reduces acute inflammation显示文摘 | Cuzzocrea S Pisano B Dugo L | 2004 | Pharmacology2004，483，1： | 1 |
| 13 | Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation 显示文摘 | Cuzzocrea S Pisano B Dugo L | 2004 | Eur J Pharmacol2004，483，1： | 1 |
| 14 | Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice显示文摘 | Cuzzocrea S Pisano B Dugo L | 2004 | Crit Care Med2004，32，45： | 1 |
| 15 | Assessment of fluid responsiveness pa- rameters for off-pump coronary artery bypass surgery : a comparison among LiD- CO, transesophageal echochardiography, and pulmonary artery catheter显示文摘 | Belloni L Pisano A Natale A | 2008 | J Cardiothorac Vase Anesth2008，22，2： | 1 |
| 16 | A Broadband WRI0 Turnstile Junction Orthomode Transducer 显示文摘 | PISANO G PIETRANERA L | 2007 | IEEE Microwave and Wireless Components Letters2007，17，4： | 1 |
| 17 | Roslglitazone, a ligand of the peroxisome prolifcrator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein 显示文摘 | Cuzzocrea S Pisano B Dugo L | 2004 | Intensive Care Med2004，30，5： | 1 |
| 18 | Rosiglitazone, a ligand of the peroxisome proliferator - activated receptor - gamma, reduces acute pancreatitis induced by cerulein显示文摘 | Cuzzocrea S Pisano B Dugo L | 2004 | Intensive Care Medicine2004，30，5： | 1 |
| 19 | Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice 显示文摘 | Cuzzocrea S Pisano B Dugo L | 2004 | Crit Care Med2004，32，2： | 1 |
| 20 | Liquid-vapor phase transition and bubble formation in micro structures 显示文摘 | Lin L Udell K S Pisano A P | 1994 | Thermal Science and Engineering1994，2，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员